Physician profile
Beverly Nelson
NPI 1730619891
$8,129.45
in general payments reported to CMS, 2019-2025
40 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,576 · 2022: $1,868 · 2023: $1,836 · 2024: $1,728 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,685.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,546.27 | 2021-2025 | Lokelma, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $748.88 | 2021-2025 | |
| Abbvie INC. | $606.24 | 2021-2025 | |
| Glaxosmithkline, LLC. | $529.68 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $490.85 | 2021-2025 | Mounjaro, Jardiance |
| Novo Nordisk INC | $470.19 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $407.57 | 2021-2025 | Evenity, Prolia, Krystexxa |
| Xeris Pharmaceuticals, INC. | $370.53 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $365.32 | 2021-2024 | Verquvo, Belsomra |
| Pfizer INC. | $238.66 | 2021-2024 | |
| Grt US Holding, INC. | $236.89 | 2022 | |
| Abbott Laboratories | $223.59 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Corcept Therapeutics | $175.98 | 2021-2023 | Korlym |
| Eisai INC. | $174.57 | 2024-2025 | |
| Exact Sciences Corporation | $161.88 | 2023-2025 | Cologuard Collection Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.